Experimental Therapy May Lead To Macular Degeneration

Science Centric

Having discovered a genetic trigger for age-related macular degeneration, the leading cause of vision loss in people over 50, researchers report that an experimental state-of-the-art therapy for treating eye disease could adversely affect the vision of some patients with the 'wrong' genetic makeup.